Skip to main content

Advertisement

Springer Nature Link
Log in

Remission of membranoproliferative glomerulonephritis type I with the use of tacrolimus

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Membranoproliferative glomerulonephritis, albeit uncommon, is associated with considerable morbidity and mortality in children. Corticosteroids are the mainstay of therapy for severe disease, although data supporting their use are limited. We report our experience in treating two children with nephrotic–nephritic syndrome from idiopathic membranoproliferative glomerulonephritis. Both children experienced a suboptimal response to prolonged courses of steroids and were started on tacrolimus as a steroid-sparing agent. Rapid and complete remission was achieved in both children after initiation of tacrolimus. The purpose of our report is to increase awareness of health care professionals to the potential benefits of this agent in inducing remission in children with severe membranoproliferative glomerulonephritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Barbiano di Belgiojoso G, Baroni M, Pagliari B, Lavagni MG, Porri MT, Banfi G, Colasanti G, Confalonieri R (1985) Is membranoproliferative glomerulonephritis really decreasing? A multicentre study of 1,548 cases of primary glomerulonephritis. Nephron 40:380–381

    Article  CAS  Google Scholar 

  2. Arslan S, Saatci U, Ozen S, Bakkaloglu A, Besbas N, Tinaztepe K, Hayran M (1997) Membranoproliferative glomerulonephritis in childhood: factors affecting prognosis. Int Urol Nephrol 29:711–716

    Article  CAS  Google Scholar 

  3. Habib R, Kleinknecht C, Gubler MC, Levy M (1973) Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. Clin Nephrol 1:194–214

    CAS  PubMed  Google Scholar 

  4. Karakayali FY, Ozdemir H, Kivrakdal S, Colak T, Emiroglu R, Haberal M (2006) Recurrent glomerular diseases after renal transplantation. Transplant Proc 38:470–472

    Article  CAS  Google Scholar 

  5. D’Amico G, Ferrario F (1992) Mesangiocapillary glomerulonephritis. J Am Soc Nephrol 2:S159–S166

    PubMed  Google Scholar 

  6. Tarshish P, Bernstein J, Tobin JN, Edelmann CM Jr (1992) Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone—a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 6:123–130

    Article  CAS  Google Scholar 

  7. Levin A (1999) Management of membranoproliferative glomerulonephritis: evidence-based recommendations. Kidney Int (Suppl)70:S41–S46

    Article  Google Scholar 

  8. Bergstein JM, Andreoli SP (1995) Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy. Pediatr Nephrol 9:268–271

    Article  CAS  Google Scholar 

  9. Jones G, Juszczak M, Kingdon E, Harber M, Sweny P, Burns A (2004) Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids. Nephrol Dial Transplant 19:3160–3164

    Article  Google Scholar 

  10. Xia Z, Liu G, Gao Y, Fan Z, Fu Y, Zhang LF, Ren X, Gao C (2006) FK506 in the treatment of children with nephrotic syndrome of different pathological types. Clin Nephrol 66:85–88

    Article  CAS  Google Scholar 

  11. Cansick JC, Lennon R, Cummins CL, Howie AJ, McGraw ME, Saleem MA, Tizard EJ, Hulton SA, Milford DV, Taylor CM (2004) Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis. Nephrol Dial Transplant 19:2769–2777

    Article  Google Scholar 

  12. Butani L, Radsliff E, Makker S (2003) Tacrolimus induces remission in children with steroid-resistant nephrotic syndrome. J Am Soc Nephrol 14:39A

    Google Scholar 

  13. Kiyomasu T, Shibata M, Kurosu H, Shiraishi K, Hashimoto H, Hayashidera T, Akiyama Y, Takeda N (2002) Cyclosporin A treatment for membranoproliferative glomerulonephritis type II. Nephron 91:509–511

    Article  Google Scholar 

  14. Ahsan N, Manning EC, Dabbs DJ, Gifford RR, Yang HC (1997) Recurrent type I membranoproliferative glomerulonephritis after renal transplantation and protective role of cyclosporine in acute crescentic transformation. Clin Transplant 11:9–14

    CAS  PubMed  Google Scholar 

  15. Cahen R, Trolliet P, Dijoud F, Megri K, Francois B (1995) Severe recurrence of type I membranoproliferative glomerulonephritis after transplantation: remission on steroids and cyclophosphamide. Transplant Proc 27:1746–1747

    CAS  PubMed  Google Scholar 

  16. Iyengar A, Karthik S, Kumar A, Biswas S, Phadke K (2006) Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome. Indian Pediatr 43:14–19

    Google Scholar 

  17. Singh A, Tejani C, Tejani A (1999) One-center experience with cyclosporine in refractory nephrotic syndrome in children. Pediatr Nephrol 13:26–32

    Article  CAS  Google Scholar 

  18. Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Bjorn Brekke I, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J (2002) Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 17:141–149

    Article  Google Scholar 

  19. Filler G, Grygas R, Mai I, Stolpe HJ, Greiner C, Bauer S, Ehrich JH (1997) Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants. Nephrol Dial Transplant 12:1668–1671

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Section of Nephrology, University of California Davis Medical Center, 2516 Stockton Boulevard, Sacramento, CA, 95817, USA

    Maha Haddad, Keith Lau & Lavjay Butani

Authors
  1. Maha Haddad
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Keith Lau
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Lavjay Butani
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Lavjay Butani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haddad, M., Lau, K. & Butani, L. Remission of membranoproliferative glomerulonephritis type I with the use of tacrolimus. Pediatr Nephrol 22, 1787–1791 (2007). https://doi.org/10.1007/s00467-007-0523-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-007-0523-1

Keywords